Rubrik: Biotechnologie
(Treffer aus Tech4Pharma, Nr. 02, Seite 74 (2026))
Schober L | Shinshikova S | Saal H | Traube A
Modular matrix production / Future prospects for cell and gene therapies · Schober L, Shinshikova S, Saal H, Traube A · KyooBe Tech und
Cell and gene therapies ATMP Production processes Modular platform Pharmaceutical plant design The manufacture of cell and gene therapies faces numerous challenges: high costs, complex processes, and a lack of standardization and scalability are hindering widespread access. While the number of approved cell and gene therapies is growing and the first products are finding their way into broader clinical application, many manufacturing processes remain fragmented, manual, and only transferable to a limited extent. The industry is therefore faced with the task of developing new manufacturing approaches that balance quality, safety, and efficiency while remaining flexible enough to respond to product ...